3-EMC
3-EMC (3-ethylmethcathinone) is the meta-substituted isomer of 4-EMC, a synthetic cathinone sold as a research chemical. Like other meta cathinone isomers it is reported to be more stimulating and less entactogenic than its para counterpart. No human pharmacology has been formally characterised, and all effect and dose information is anecdotal.
01 Overview
3-EMC is a ring-substituted cathinone marketed as a legal-grey stimulant. Positioning of the ethyl group at the meta position is associated in user reports with a sharper, more purely stimulating character than the 4-position isomer.
The class hazards apply in full: compulsive redosing, cardiovascular strain, harsh comedown and unknown neurotoxicity. There are no controlled human studies, so figures are approximate and drawn from user reports.
02 Mechanism
Presumed monoamine releaser and reuptake inhibitor at dopamine, noradrenaline and serotonin transporters, with meta substitution favouring catecholamine over serotonin activity.
03 Dosing
| Tier | Dose | Route | Notes |
|---|---|---|---|
| Common | 50–100 mg | Insufflated | Faster, harsher, more compulsive. |
| Common | 100–200 mg | Oral | Anecdotal only. |
04 Effects
| Effect | Magnitude | Evidence | |
|---|---|---|---|
| StimulationEnergy and alertness, reported as sharper than 4-EMC. | Anecdotal | ||
| Increased sociabilityTalkativeness and confidence. | Anecdotal | ||
| Appetite suppressionReduced hunger during effects. | Anecdotal |
05 Side effects
| Effect | Severity | Frequency | Evidence | Countermeasures |
|---|---|---|---|---|
| Compulsive redosingUrge to redose repeatedly, driving binges. | Moderate | Most users | Anecdotal | |
| Cardiovascular strainTachycardia and hypertension. | Severe | Common | Unconfirmed | |
| InsomniaDifficulty sleeping for hours after use. | Mild | Common | Anecdotal |